Target intelligence / Profile preview

Follicle-stimulating hormone receptor messenger RNA (FSHR mRNA) (FSHR mRNA)

Target
FSHR mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Follicle-stimulating hormone receptor messenger RNA (FSHR mRNA) is the nucleic acid transcript responsible for the synthesis of the FSHR protein, a G protein-coupled receptor essential for mammalian reproductive function (NCBI Gene ID: 2492). In females, it is primarily expressed in ovarian granulosa cells, where it facilitates follicle maturation and estrogen production; in males, it is expressed in Sertoli cells to support spermatogenesis (UniProt: P23945). Targeting the mRNA transcript via RNA interference (RNAi) or antisense oligonucleotides (ASOs) represents a therapeutic strategy to silence FSHR expression, which is particularly relevant in treating FSHR-overexpressing malignancies like ovarian cancer or managing conditions like endometriosis (PMID: 17063136, PMID: 25600153). Beyond reproduction, FSHR mRNA expression has been detected in extragonadal tissues, suggesting its potential involvement in bone health and metabolic regulation, though these roles remain areas of active investigation (PMID: 31164557). Additionally, the detection of FSHR mRNA in circulating tumor cells is being explored as a diagnostic and prognostic biomarker in various hormone-dependent cancers.

Other names
FSH receptor mRNAFSHR transcriptFollicle-stimulating hormone receptor transcriptFSH-R mRNA
02

Mechanism of action

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to prevent translation into the FSHR protein.

03

Biological functions

Translation template for FSHR proteinRegulation of follicle-stimulating hormone signalingOvarian follicle developmentSpermatogenesisSteroidogenesis regulation
04

Disease associations

Ovarian cancerEndometriosisPolycystic ovary syndrome (PCOS)Ovarian hyperstimulation syndrome (OHSS)Infertility
05

Safety considerations

Primary ovarian insufficiencyDisruption of the hypothalamic-pituitary-gonadal axisOff-target effects of oligonucleotide therapyPotential impact on bone mineral density
06

Interacting drugs

Experimental FSHR-targeting siRNAs

1 more in the full profile.

07

Biomarkers

FSHR mRNA expression levels in tissueCirculating tumor cells (CTCs) expressing FSHR mRNASerum follicle-stimulating hormone (FSH) levelsSerum estradiol levels

Beyond the preview

Go deeper on Follicle-stimulating hormone receptor messenger RNA (FSHR mRNA) (FSHR mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Follicle-stimulating hormone receptor messenger RNA (FSHR mRNA) (FSHR mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call